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Volume 57, Number 1 Abstracts 291generated a higher net revenue than symptomatic patients, whether
undergoing CEA or CAS.
Conclusions: Hospital reimbursement for CAS was 18% higher than
that for CEA. However, CEA was associated with a 33% higher net income
because of the 40% cost premium of CAS. Asymptomatic patients have the
lowest cost and highest net income of all the subgroups, likely due to less
complex clinical presentation and associated testing. At present, CAS is not
routinely cost-effective in a fee-for-service or capitated health care environ-
ment.
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Objectives: Extracranial carotid artery aneurysms (ECCA) are ex-
tremely rare, with limited information regarding management options.
Our purpose was to review our institution’s experience with ECCA over
15 years.
Methods: A retrospective review of patients diagnosed with ECCA
from 1998 to 2012 was performed. Symptoms, risk factors, etiology, diag-
nostic methods, treatments, and outcomes were reviewed.
Results: A total of 141 aneurysms were diagnosed in 132 patients
(69 men; mean age, 61 years). There were 116 (82%) pseudoaneurysms
and 25 (18%) true aneurysms: 114 (81%) aneurysms involved the internal
carotid, 11 common (8%), 15 the bifurcation (10%), and one external
(1%). A total of 69 aneurysms (49%) were asymptomatic and 72 (51%)
had symptoms (28 painless mass, 10 TIAs, 10 vision symptoms, 9
ruptures, 8 strokes, 4 painful mass, 1 dysphagia, 1 tongue weakness, 1
bruit). Diagnosis was by MR in 61 (43%), CT in 40 (28%), ultrasound in
29 (21%), angiography in nine (6.5%), and after rupture in two (1.5%).
Etiologies for true aneurysms included fibromuscular dysplasia in 15
patients, Ehlers Danlos in three, Marfan in one, and uncharacterized
connective tissue diseases in two. A total of 11 of 25 true aneurysms
(44%) were symptomatic, 15 (60%) true aneurysms underwent open
surgical treatment, and 10 (40%) were managed nonoperatively. Surgical
procedures included 14 (93%) aneurysmectomies with reconstruction (7
end-to-end, 4 saphenous interposition, 3 prosthetic interposition) and
one (7%) aneurysmorrhaphy. Postoperative complications included one
stroke during a mean follow-up of 31 months (range, 0-166 months). No
aneurysms managed nonoperatively required intervention during a mean
follow-up of 77 months (range, 1-115 months). Sixty of 116 pseudoan-
eurysms (52%) were symptomatic. Thirty-three pseudoaneurysms (29%)
underwent open surgery, 18 (15%) underwent endovascular interven-
tion, and 65 (56%) were managed medically. Pseudoaneurysm after
endarterectomy (28 patients, 24%) presented at a mean of 82 months
from the surgical procedure. Mean follow-up for all aneurysms was 33.9
months. One (0.7%) aneurysm-related death occurred (rupture treated
palliatively). No patient undergoing nonoperative management died or
suffered major morbidity related to the aneurysm. Nonoperative man-
agement was more common in asymptomatic patients (71%) than in
symptomatic patients (31%).
Conclusions: ECCA are uncommon and may present with varying
symptoms. All segments of the carotid artery are susceptible, although the
Fig.internal is most commonly affected. Open surgical intervention was more
common in patients with symptoms and with true aneurysms. Patients with iseudoaneurysms were more likely to undergo endovascular intervention.
onoperative treatment is safe in selected patients.
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Objectives: Carotid occlusive disease is a major cause of stroke, ac-
ounting for 20% to 25% of cases in the USA. Several studies have described
higher incidence of stroke and attributed mortality in minority ethnic
roups. This study used a national database to identify ethnic disparity in
erms of risk profile, clinical presentation, and outcome in patients under-
oing carotid endarterectomy.
Methods: Using National Surgical Quality Improvement Program
NSQIP) data file from years 2005 to 2007, we identified patients under-
oing carotid endarterectomy, CPT code (35301). Patients were divided
nto two groups based on ethnicity into white and nonwhite. Patient
emographic, comorbidities, clinical presentation, postoperative morbidity,
nd mortality were compared between groups using 2 and t test as appro-
riate.
Results: Among 21,993 patients included in the study, 19,202
87.3%) were white and 2791 (12.7%) were nonwhite. The minority
onwhite group was more likely to present with symptomatic carotid
cclusive disease (7.5% vs 4.8%, P  .001), procedure was done emer-
ently (2.3% vs 1.4%, P  .001), was younger (69.8 vs 71.7 years, P 
001), and had a higher proportion of women (43.5% vs 40.9%, P 
010), The nonwhite group also had significantly higher cardiovascular
isk factors, including smoking, diabetes, coronary artery disease, history
f coronary revascularization, chronic obstructive pulmonary disease,
nd end-stage renal disease (Table). Although there was no difference in
ostoperative myocardial infarction, stroke, patients with nonwhite eth-
icity had higher overall postoperative morbidity (5.3% vs 4.0%, P 
001), mortality (1.2% vs 0.06, P  .001), and total hospital duration
3.3  6.9 vs 2.3  3.6 days, P  .001).
Conclusions: Review of the NSQIP database revealed ethnic minority
atients presented with advance carotid occlusive disease at time of carotid
urgery compared with white patients. This group also had higher postop-
rative morbidity and mortality and presented with higher number of
ardiovascular risk factors. The findings may be due to delay in seeking
reatment, limited access to care, and less rigorous screening. Further studies
re required to identify factors delaying care for carotid occlusive disease in
he nonwhite population.
able.
ariable White Nonwhite P
otal 19,202 (87.3%) 2791 (12.7%)
ymptomatic disease 925 (4.8%) 208 (7.5%) .001
mergency case 264 (1.4%) 64 (2.3%) .001
emale gender 7857 (86.6%) 1214 (13.4%) 0.01
ge, years 71.1  9.3 69.8  9.2 .001
ypertension 16,366 (85.2%) 2399 (86. %) .330
yocardial infarction 269 (1.4%) 45 (1.6%) .395
cute CHF in 30 days 150 (0.8%) 30 (1.1%) .111
OPD 2078 (10.8%) 202 (7.2%) .001
DDM 1651 (8.6%) 349 (12.5%) .001
IDDM 3411 (17.8%) 632 (22.6%) .001
moker 5296 (27.6%) 826 (29.6%) .028
CI 3635 (18.9%) 462 (2.1%) .003
ABG 4485 (23.4%) 561 (20.1%) .001
SRD 152 (0.8%) 53 (1.9%) .001
SA 3 2381 (12.4%) 380 (13.6%) .070
ostoperative variables
Stroke/CVA 296 (1.5%) 41 (1.5%) .861
Coma 24 hours 17 (0.1%) 6 (0.2%) .062
MI 120 (0.6%) 16 (0.6%) .885
SSI 42 (0.2%) 6 (0.2%) 1
Sepsis 85 (0.4%) 39 (1.4%) .001
Respiratory complications 316 (1.6%) 78 (2.8%) .001
Renal complication 37 (0.2%) 10 (0.4%) .081
Morbidity 765 (4.0%) 148 (5.3%) .001
Death 124 (0.6%) 34 (1.2%) .001
Length of surgery 114  44 119  46 .001
Duration of hospital stay 2.3  3.6 3.3  6.9 .001
SA, American Society of Anesthesiologists; CABG, coronary artery bypass
rafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary
isease; CVA, cerebrovascular accident; ESRD, end-stage renal disease; IDDM,
nsulin-dependent diabetes mellitus; MI, myocardial infarction; NIDDM, non–
nsulin-dependent diabetes mellitus; PCI, percutaneous coronary intervention.
